[1] Metlay J P, Waterer G W, Long A C, et al. Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American thoracic society and infectious diseases society of America[J]. Am J Respir Crit Care Med, 2019, 200(7): e45-e67. [2] Kalil A C, Metersky M L, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society[J]. Clin Infect Dis, 2016, 63(5): e61-e111. [3] Torres A, Cilloniz C, Niederman M S, et al. Pneumonia[J]. Nat Rev Dis Primers, 2021, 7(1): 25. [4] Weber D J, Rutala W A, Sickbert-Bennett E E, et al. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia[J]. Infect Control Hosp Epidemiol, 2007, 28(7): 825-831. [5] Moghoofei M, Azimzadeh Jamalkandi S, Moein M, et al. Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis[J]. Infection, 2020, 48(1): 19-35. [6] Lee S H, Ruan S Y, Pan S C, et al. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units[J]. J Microbiol Immunol Infect, 2019, 52(6): 920-928. [7] Yoo I Y, Huh K, Shim H J, et al. Evaluation of the BioFire FilmArray Pneumonia Panel for rapid detection of respiratory bacterial pathogens and antibiotic resistance genes in sputum and endotracheal aspirate specimens[J]. Int J Infect Dis, 2020, 95: 326-331. [8] Murphy C N, Fowler R, Balada-Llasat J M, et al. Multicenter evaluation of the BioFire FilmArray Pneumonia/Pneumonia Plus Panel for detection and quantification of agents of lower respiratory tract infection[J]. J Clin Microbiol, 2020, 58(7): e00128-20. [9] Buchan B W, Windham S, Balada-Llasat J M, et al. Practical comparison of the BioFire FilmArray Pneumonia Panel to routine diagnostic methods and potential impact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections[J]. J Clin Microbiol, 2020, 58(7): e00135-20. [10] Boix-Palop L, Obradors M, Xercavins M, et al. Improvement of pneumococcal pneumonia diagnosis using quantitative real-time PCR targeting lytA in adult patients: a prospective cohort study[J]. Clin Microbiol Infect, 2022, 28(1): 138.e1-138.e7. [11] Torres A, Lee N, Cilloniz C, et al. Laboratory diagnosis of pneumonia in the molecular age[J]. Eur Respir J, 2016, 48(6): 1764-1778. [12] van der Schalk T E, Coppens J, Timbermont L, et al. Evaluation of GeneXpert PA assay compared to genomic and (semi-)quantitative culture methods for direct detection of Pseudomonas aeruginosa in endotracheal aspirates[J]. Antimicrob Resist Infect Control, 2021, 10(1): 110. [13] Deschaght P, De Baere T, Van Simaey L, et al. Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients[J]. BMC Microbiol, 2009, 9: 244. [14] Saukkoriipi A, Palmu A A, Jokinen J, et al. Effect of antimicrobial use on pneumococcal diagnostic tests in elderly patients with community-acquired pneumonia[J]. Eur J Clin Microbiol Infect Dis, 2015, 34(4): 697-704. [15] Sun L X, Li L J, Du S S, et al. An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of lower respiratory infections-a multicenter prospective study on ICU patients[J]. Eur J Clin Microbiol Infect Dis, 2021, 40(10): 2113-2121. |